Abstract
The role of the complement system in the pathogenesis of systemic diseases is very ambivalent. In systemic lupus erythematosus (SLE), many abnormalities in the activation of the complement system have been reported. The most important antibodies formed against the complement system in SLE are the ones associated with the C1q component. The aim of this study was to assess separately the anti-C1q antibodies and C1q component in the serum from 65 patients with SLE, then in individuals with (n=33) and without (n=32) lupus nephritis and with active (n=36) and nonactive (n=29) form of the disease (European Consensus Lupus Activity Measurement, ECLAM>3, ECLAM≤3). This study also aims to look for correlations with other clinical and laboratory parameters. The C1q antibodies were measured by the Enzyme-Linked Immunosorbent Assay (ELISA) test, while radial immunodiffusion according to Mancini was used to measure the C1q complement component. The mean serum levels were 90.89±13 IU/ml for anti-C1q antibodies and 145±52 mg/l for C1q. The significant difference in C1q antibodies levels was found between individuals with and without lupus nephritis (117.5±52 IU/ml vs. 28.2±12.2 IU/ml, p=0.0001) and between those with active and nonactive SLE (154.6±115 IU/ml vs. 50.6±73, p=0.001). C1q complement component was statistically lower in patients with lupus nephritis (144±30 mg/l vs. 175±50 mg/ml, p=0.002) and in active patients (138±40 mg/l vs. 202±20 mg/l, p=0.001). If the two parameters are measured together, they seem to have a mirror-like pattern of serum concentration, and they are potential markers of SLE activity and of the presence of lupus nephritis.
Similar content being viewed by others
References
Herrmann M, Voll RE, Lolowos W et al (2000) Pathogenesis of systemic lupus erythematosus. Immunologist 8:345–350
Walport MJ (2002) Complement and systemic lupus erythematosus. Arthritis Res 4[Suppl 3]:S279–S293
Botto M, Walport MJ (2002) C1q, autoimmunity and apoptosis. Immunobiology 205:395–406
Monova D, Monov S, Rosenova K et al (2002) Autoantibodies against C1q: view on association between systemic lupus erythematosus disease manifestation and C1q autoantibodies. Ann Rheum Dis 61:563–564
Pickering MC, Walport MJ (2003) The complement system. In: Hochberg MC, Silman AJ, Smolen JS (eds) Rheumatology. 3rd edn, Mosby, pp 1323–1336
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Bencivelli W, Vitali C, Isenberg DA et al and the European Consensus Study Group for Disease Activity in SLE (1992) Disease activity in systemic lupus erythematosus: Report of the consensus study group of the European workshop for rheumatology research. III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 10:549–554
Bombardier C, Gladman DD, Urowitz MB et al. and The comittee on prognosis studies in SLE: Derivation of SLEDAI (1992) Arthritis Rheum 35:630–640
Fremeaux-Bacchi V, Noel LH, Schifferli JA (2002) No lupus nephritis in the absence of anti-C1q autoantibodies? Nephrol Dial Transplant 17:2041–2043
Gladman DD, Urowitz MB (1999) The SLICC/ACR damage index: progress report and experience in the field. Lupus 8:632–637
Horvath L, Czirjak L, Fekete B et al. (2001) High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 19:667–672
Horák P, Hermanová Z, Ordeltová J et al (2004) C1q complement component and apoptotic indices of B and T lymphocytes in the group of patients with systemic lupus erythematosus. Ces revmatol 12:69–75 (Czech)
Navratil JS, Korb LC, Ahearn JM (1999) Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42:47–52
Trendelenburg M, Schifferli JA (2000) Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus. Z Rheumatol 59:172–175 (German)
Kumar A, Gupta R, Varghese T et al (1999) Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian J Med Res 10:190–193
Oelzner P, Deliyska B, Funfstuck R, Hein G, Herrmann D, Stein G (2003) Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus — relationship with disease activity and renal involvement. Clin Rheumatol 22:271–278
Wisnieski JJ, Naff GB (1989) Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 32:1119–1127
Siegert CE, Daha MR (1998) C1q as antigen in humoral autoimmune responses. Immunobiology 199:295–302
Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285
Berner B, Scheel AK, Schettler V et al (2001) Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis 80:898–899
Pfueller B, Wolbart K, Bruns A et al (2001) Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum 44:1962–1963
Stone NM, Williams A, Wilkinson JD et al (2000): Systemic lupus erythematosus with C1q deficiency. Br J Dermatol 142:521–524
Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525–4528
Pickering MC, Botto M, Taylor PR et al (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–234
Berkel AL, Petry F, Sanal O et al (1997) Development of systemic lupus erythematosus in a patient with selective complement C1q deficiency. Eur J Pediatr 156:113–115
Mitchell DA, Pickering MC, Warren J et al (2002) C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168:2538–2543
Acknowledgement
Financial support of GRANT IGA č. NR 8406.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horák, P., Heřmanová, Z., Zadražil, J. et al. C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 25, 532–536 (2006). https://doi.org/10.1007/s10067-005-0110-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0110-4